Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of CD7 CAR-T Cells in Adult Refractory and Recurrent T-cell Lymphoma/Leukemia

NCT05620680 is registered in ClinicalTrials.gov with Shenzhen University General Hospital as lead sponsor.

NCT NCT05620680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05620680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of CD7 CAR-T Cells in Adult Refractory and Recurrent T-cell Lymphoma/Leukemia
Lead sponsor
Shenzhen University General Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
October 1, 2022
Completion date
October 31, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

t lymphoblastic leukemia/lymphoma